NCT05752188View on ClinicalTrials.gov

Prognostic Value of Cardiovascular Risk of sST2 and Troponin I-hs in Patients With Acute Chest Pain

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 3, 2021

Primary Completion Date

September 8, 2022

Study Completion Date

September 24, 2024

Conditions
Acute Chest PainAcute Coronary Syndrome
Interventions
OTHER

Multimarker approach in acute coronary syndrome

The main objective of the study is to evaluate the prognostic role of the biochemical marker sST2 in patients attending the Emergency Department of our hospital with acute chest pain with suspected acute coronary syndrome.

Trial Locations (1)

00168

Silvia Baroni, Roma

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER